~~<i id='368697030A'><strike id='368697030A'><tt id='368697030A'><pre id='368697030A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：entertainment 2025-10-01 11:45:10 - browse：23

translucent 3D DNA helix with blue and purple background — Adobe

Verve Therapeutics said Monday that it had received clearance from the Food and Drug Administration to conduct a clinical trial in the U.S. of its experimental, gene-editing treatment for a common form of heart disease.

The FDA’s action removes a clinical hold on Verve’s CRISPR-based therapy, called VERVE-101, that was placed on it last November. Verve now intends to recruit participants from U.S. sites into a Phase 1 study that’s been underway since last year in New Zealand and the United Kingdom.

“We’re thrilled to get this clearance for VERVE-101,” said Verve CEO Sek Kathiresan. “Our study is called HEART-1 and our plan now is to activate U.S. sites.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

leisure time

entertainment

focus

knowledge

focus

leisure time

ALAINJOCARD/AFPviaGettyImagesFormorethan30years,Alzheimer’sresearchershavethoughtofAPOE4asamajorgene

WSS

Harvard scientists, with Google, unveil the most detailed brain map ever

Hundreds died while taking an arthritis drug, but nobody alerted patients

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

He's a Nobel laureate. Critics say he was misleading on Covid

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

explore

explore

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

How to save PrEP access — and even expand it

Alabama hospital puts IVF treatments on hold

What does generative AI mean for health care? We asked experts

Harvard scientists, with Google, unveil the most detailed brain map ever

Anesthesiologist group: stop taking Ozempic before surgery

Oral obesity drug from Viking Therapeutics hits key early target

Supreme Court strikes down use of affirmative action

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

entertainment

A new nitrogen execution bill also undermines medical licensing

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Scientists uncover potential path to treating deadly childhood tumor

New documents shed light on MD Anderson Cancer Institute feud

Hundreds died while taking an arthritis drug, but nobody alerted patients

Bird flu in dairy cattle: New measures to control spread to humans

focus

knowledge

focus

leisure time